Disease gene identification: ethical considerations.
How can we offer genetic testing and screening with adequate protection? Who will have access to the results? How do we balance a person's desire to know with the pain that knowledge may bring? We can examine these issues in the light of our experience with two fatal autosomal diseases: cystic fibrosis, in which the gene is known, and Huntington's disease, in which it is not.
Wexler
N S
NS
Department of Neurology, Columbia University College of Physicians and Surgeons.
D003550:Cystic Fibrosis / Q000175:diagnosis / Q000235:genetics; D004992:Ethics, Medical; D005260:Female; D005315:Fetal Diseases / Q000175:diagnosis; D005817:Genetic Counseling; D005820:Genetic Testing; D006801:Humans; D006816:Huntington Disease / Q000175:diagnosis / Q000235:genetics; D011247:Pregnancy; D011296:Prenatal Diagnosis